Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

α7nAChR activation protects against oxidative stress, neuroinflammation and central insulin resistance in ICV-STZ induced sporadic Alzheimer's disease
P. Yamini, R. S. Ray, Sonal Yadav, et al.
Pharmacology Biochemistry and Behavior (2022) Vol. 217, pp. 173402-173402
Closed Access | Times Cited: 22

Showing 22 citing articles:

Preclinical Models for Alzheimer’s Disease: Past, Present, and Future Approaches
Ansab Akhtar, Shraddha Manish Gupta, Shubham Dwivedi, et al.
ACS Omega (2022) Vol. 7, Iss. 51, pp. 47504-47517
Open Access | Times Cited: 41
Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets
Aparna Chauhan, Sachin Dubey, Smita Jain
Cell Biochemistry and Function (2024) Vol. 42, Iss. 7
Closed Access | Times Cited: 5
Research Progress on the Mechanisms of Protocatechuic Acid in the Treatment of Cognitive Impairment
Shuzhi Liang, Zhong-Min Zhao, Leilei Liu, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4724-4724
Open Access | Times Cited: 4
Modulation of the cognitive impairment associated with Alzheimer’s disease by valproic acid: possible drug repurposing
Mirna Ezzat Sedrak Sorial, Ragwa Mansour Abdelghany, Nesrine S. El Sayed
Inflammopharmacology (2025)
Open Access
FGF-18 alleviates memory impairments and neuropathological changes in a rat model of Alzheimer's disease
Arzuhan ÇETİNDAĞ ÇİLTAŞ, Sebahattin Karabulut, Bilal Şahin, et al.
Neuropeptides (2023) Vol. 101, pp. 102367-102367
Closed Access | Times Cited: 10
The volatile oil of Acorus tatarinowii Schott ameliorates Alzheimer's disease through improving insulin resistance via activating the PI3K/AKT pathway
Junhao Huang, Zhiwei Xu, C. C. Yu, et al.
Phytomedicine (2024) Vol. 135, pp. 156168-156168
Closed Access | Times Cited: 3
Neuroprotective potential of tranilast in streptozotocin-induced sporadic Alzheimer's disease model targeting TXNIP-NLRP3 inflammasome pathway
Dibya Sundar Padhy, Kushal Vesmaker, Sugato Banerjee
International Immunopharmacology (2025) Vol. 156, pp. 114691-114691
Closed Access
Voglibose attenuates cognitive impairment, Aβ aggregation, oxidative stress, and neuroinflammation in streptozotocin-induced Alzheimer’s disease rat model
Manickam Rajkumar, Soundarapandian Kannan, Ramasundaram Thangaraj
Inflammopharmacology (2023) Vol. 31, Iss. 5, pp. 2751-2771
Closed Access | Times Cited: 9
New insights into glycogen synthase kinase-3: A common target for neurodegenerative diseases
Chengfeng Wang, Yu Cui, Tong Xu, et al.
Biochemical Pharmacology (2023) Vol. 218, pp. 115923-115923
Closed Access | Times Cited: 8
Potential bioactive compounds and mechanisms of Fibraurea recisa Pierre for the treatment of Alzheimer’s disease analyzed by network pharmacology and molecular docking prediction
Shishuai Wang, Yixuan Ma, Yu‐Ping Huang, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 13
Beneficial effect of lupeol and metformin in mouse model of intracerebroventricular streptozotocin induced dementia
K Rohatgi Ram, Kuldeep Kumar, Dhandeep Singh, et al.
Metabolic Brain Disease (2024) Vol. 39, Iss. 5, pp. 661-678
Closed Access | Times Cited: 2
Chitosan/PLA-loaded Magnesium oxide nanocomposite to attenuate oxidative stress, neuroinflammation and neurotoxicity in rat models of Alzheimer's disease
Manickam Rajkumar, Prabha Govindaraj, Karuppaiya Vimala, et al.
Metabolic Brain Disease (2023) Vol. 39, Iss. 4, pp. 487-508
Closed Access | Times Cited: 6
RETRACTED: Gelatin/polyethylene glycol-loaded magnesium hydroxide nanocomposite to attenuate acetylcholinesterase, neurotoxicity, and activation of GPR55 protein in rat models of Alzheimer's disease
Manickam Rajkumar, Sundarraj Navaneethakrishnan, S Muthukumar, et al.
Journal of Chemical Neuroanatomy (2023) Vol. 133, pp. 102337-102337
Closed Access | Times Cited: 5
Nicotinamide, an acetylcholinesterase uncompetitive inhibitor, protects the blood‒brain barrier and improves cognitive function in rats fed a hypercaloric diet
Armando Ramírez-Cruz, Beatriz Gómez‐González, Luis Arturo Baiza‐Gutman, et al.
European Journal of Pharmacology (2023) Vol. 959, pp. 176068-176068
Closed Access | Times Cited: 5
Activation of the α7 Nicotinic Acetylcholine Receptor Prevents against Microglial-Induced Inflammation and Insulin Resistance in Hypothalamic Neuronal Cells
Camila Libardi do Amaral, Ísis de Cássia Alves Martins, Alana Carolina Costa Verás, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2195-2195
Open Access | Times Cited: 8
Small molecule ligands for α9 * and α7 nicotinic receptors: A survey and an update, respectively
Alessandro Giraudo, Marco Pallavicini, Cristiano Bolchi
Pharmacological Research (2023) Vol. 193, pp. 106801-106801
Open Access | Times Cited: 4
Tetrahydroalstonine possesses protective potentials on palmitic acid stimulated SK-N-MC cells by suppression of Aβ1-42 and tau through regulation of PI3K/Akt signaling pathway
Kang Chen, Guran Yu
European Journal of Pharmacology (2023) Vol. 962, pp. 176251-176251
Closed Access | Times Cited: 3
Biochemical investigation and in silico analysis of the therapeutic efficacy of Ipriflavone through Tet-1 Surface-Modified-PLGA nanoparticles in Streptozotocin-Induced Alzheimer’s like Disease: Reduced oxidative damage and etiological Descriptors
Samar R. Saleh, Salma E Khamiss, Somaya Aly Madhy, et al.
International Journal of Pharmaceutics (2024) Vol. 669, pp. 125021-125021
Closed Access
Animal Models and Ethics in the Testing of Drugs for Alzheimer’s Disease
Parikshit Roychowdhury, Antony Justin, Mirunalini Gobinath, et al.
(2024), pp. 333-360
Closed Access
Increased brain cytokine level associated impairment of vigilance and memory in aged rats can be alleviated by alpha7 nicotinic acetylcholine receptor agonist treatment
Zsolt Kristóf Bali, Lili Veronika Nagy, Nóra Bruszt, et al.
GeroScience (2023)
Open Access | Times Cited: 1
Neuroprotective and memory enhancing effect of Nose to Brain formulation of 6- Hydroxyflavone in icv-STZ-induced Alzheimer's disease mouse model
Hitesh Patil, Chandrakant Pardeshi, Siddheshwar Khule, et al.
Research Square (Research Square) (2023)
Open Access
Chitosan/PLA-loaded Magnesium oxide nanocomposite to attenuate oxidative stress, neuroinflammation, and neurotoxicity in rat models of Alzheimer's disease
Manickam Rajkumar, Prabha Govindaraj, Karuppaiya Vimala, et al.
Research Square (Research Square) (2023)
Closed Access
Page 1

Scroll to top